Skip to main content
TipRanks
Go Ultimate75% OFF

Yuki Gosei Kogyo Co., Ltd. (4531) AI Stock Analysis

0 Followers
JP:4531

Yuki Gosei Kogyo Co., Ltd.

(TSE/TYO:4531)

Select Model
Rating:59Neutral
Price Target:JPY 330.00▼(-0.90% Downside)
Action:reiterated
Date:09/24/26

The score is driven mainly by moderate financial fundamentals: earlier improvements are tempered by the 2026 earnings decline and historically inconsistent free cash flow (despite a strong rebound in 2026). Technicals are neutral-to-soft with a negative MACD and price below the 200-day average. Valuation is reasonable with a mid-range P/E and a supportive dividend yield, but not compelling enough to lift the overall rating materially.

Positive Factors
Balance-sheet stabilityA consistently larger equity base than total debt provides financial resilience and supports continued operations through periods of weaker earnings. Moderate leverage also preserves more flexibility for investment and capital allocation than a highly debt-dependent balance sheet would allow.
Negative Factors
2026 earnings deteriorationThe sharp fall in net income, combined with a revenue decline, signals weakened operating performance rather than merely slower growth. Persistent earnings pressure could reduce internally funded investment, weaken returns, and make the earlier improvement less durable.

Yuki Gosei Kogyo Co., Ltd. (4531) vs. iShares MSCI Japan ETF (EWJ)

-20%0%20%40%60%80%100%JP:4531+20.22%EWJ+15.75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 7.15B
Dividend Yield
3.00%
Average Volume (3M)
44.09K
Price to Earnings (P/E)
15.0
Beta (1Y)
1.27
Revenue Growth
3.90%
EPS Growth
-31.32%
Country
Japan
Employees
296
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Yuki Gosei Kogyo Co., Ltd. Business Overview & Revenue Model

Company Description

Yuki Gosei Kogyo Co., Ltd. is a Japanese enterprise that globally researches, develops, produces, and markets sophisticated fine chemical products. Their diverse portfolio encompasses food-grade additives, pharmaceutical components, and chemicals for...

Yuki Gosei Kogyo Co., Ltd. Financial Statement Overview

Summary

Multi-year improvement through 2025 is offset by a clear 2026 step-down: revenue turned slightly negative (-2.6%) and net income fell sharply (313M vs 896M in 2025), signaling margin/cost pressure. Balance sheet is generally stable with equity above debt and moderate leverage, but debt rose in 2025 and remains elevated. Cash flow improved meaningfully in 2026 (positive FCF after several negative years), yet the prior multi-year volatility keeps confidence moderate.

Income Statement

61Positive

Balance Sheet

68Positive

Cash Flow

54Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue15.74B15.45B15.13B12.93B12.84B12.36B
Gross Profit2.49B2.55B3.23B3.26B3.05B2.36B
EBITDA1.46B1.62B2.23B1.93B1.62B1.24B
Net Income417.00M313.00M896.00M776.00M556.00M248.00M
Balance Sheet
Total Assets25.79B25.73B27.29B24.75B22.35B21.38B
Cash, Cash Equivalents and Short-Term Investments1.39B885.00M973.00M588.00M1.14B1.86B
Total Debt6.36B6.71B8.51B6.87B5.58B5.54B
Total Liabilities12.41B12.24B14.18B12.31B10.87B10.38B
Stockholders Equity13.38B13.49B13.11B12.43B11.48B11.00B
Cash Flow
Free Cash Flow01.72B-1.20B-1.37B-490.00M1.40B
Operating Cash Flow02.84B2.14B388.00M668.00M1.79B
Investing Cash Flow0-1.01B-3.25B-1.89B-1.24B-442.00M
Financing Cash Flow0-1.92B1.50B948.00M-158.00M-772.00M

Yuki Gosei Kogyo Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price333.00

Price Trends

50DMA358.36Negative
100DMA357.68Negative
200DMA377.43Negative

Market Momentum

MACD-9.71Positive
RSI37.75Neutral
STOCH33.33Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4531, the sentiment is Negative. The current price of 333.00 is below the 20-day moving average (MA) of 351.55, below the 50-day MA of 358.36, and below the 200-day MA of 377.43, indicating a bearish trend. The MACD of -9.71 indicates Positive momentum. The RSI at 37.75 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4531.

Yuki Gosei Kogyo Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:4531 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4041JP:404184OutperformJPY 191.84B10.41―4.82%-1.25%34.70%
JP:4040JP:404079OutperformJPY 9.55B2.74―1.60%0.56%238.99%
JP:4093JP:409369NeutralJPY 13.88B11.06―3.44%-0.22%4.42%
JP:4970JP:497061NeutralJPY 56.75B16.31―0.66%20.83%89.46%
JP:4531JP:453159NeutralJPY 7.29B15.03―3.00%3.90%-31.32%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4366JP:436648NeutralJPY 14.15B12.16―1.87%10.12%43.23%

* General Sector Average

Performance Comparison

0%50%100%150%JP:4531JP:4040JP:4041JP:4093JP:4366JP:4970Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4531 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4531Yuki Gosei Kogyo Co., Ltd.333.0059.9121.94%
JP:4040NANKAI CHEMICAL COMPANY LIMITED4050.00951.3230.70%
JP:4041Nippon Soda Co., Ltd.3530.0087.382.54%
JP:4093Toho Acetylene Co., Ltd.407.0066.8819.66%
JP:4366Daito Chemix Corporation439.00174.5065.97%
JP:4970Toyo Gosei Co., Ltd.7610.00930.5113.93%

Yuki Gosei Kogyo Co., Ltd. Corporate Events

Yuki Gosei Kogyo Projects Profit Rebound Despite Interim Earnings Volatility

Oct 30, 2026

Yuki Gosei Kogyo Co., Ltd., listed on the Tokyo Stock Exchange under code 4531, operates in the chemical and pharmaceutical-related sector and reports under Japanese GAAP. The company focuses on specialty chemical products, with its performance track...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 24, 2026